Biomarker development for C9orf72 repeat expansion in ALS

Brain Research

Volumn 1607, Issue , 2015, Pages 26-35

  Mendez, Emily F ^a   Sattler, Rita ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALS; Biomarker; C9orf72; FTD

Indexed keywords

BIOLOGICAL MARKER; HISTONE; MICRORNA; MOLECULAR MARKER; C9ORF72 PROTEIN, HUMAN; PROTEIN; REPETITIVE DNA;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; C9ORF72 GENE; CHROMOSOME 9P; DNA METHYLATION; EPIGENETICS; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; HISTONE MODIFICATION; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; ANIMAL; BLOOD; CEREBROSPINAL FLUID; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOMARKERS; DNA REPEAT EXPANSION; EPIGENESIS, GENETIC; HUMANS; PROTEINS;

EID: 84926201889     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.09.041     Document Type: Review

References (111)

1. A. Al-Chalabi Genetic and epigenetic studies of amyotrophic lateral sclerosis Amyotroph Lateral Scler Frontotemporal Degener 14 Suppl. 1 2013 44 52
2. S. Almeida Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons Acta Neuropathol 2013
3. P.E. Ash Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS Neuron 77 2013 639 646
4. S. Bandiera Genetic variations creating microRNA target sites in the FXN 3′-UTR affect frataxin expression in Friedreich ataxia PLoS One 8 2013 e54791
5. R.J. Bateman A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system Ann Neurol. 66 2009 48 54
6. P. Bede Multiparametric MRI study of ALS stratified for the C9orf72 genotype Neurology 81 2013 361 369
7. Belzil, V.V., et al., 2013. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol.
8. Belzil, V.V., et al., 2014. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res.
9. B.F. Boeve Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Brain 135 2012 765 783
10. R. Bowser, M. Cudkowicz, and R. Kaddurah-Daouk Biomarkers for amyotrophic lateral sclerosis Expert Rev. Mol. Diagn. 6 2006 387 398
11. R. Bowser, M.R. Turner, and J. Shefner Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations Nat. Rev. Neurol. 7 2011 631 638
12. R.M. Brena Quantification of DNA methylation in electrofluidics chips (Bio-COBRA) Nat. Protoc. 1 2006 52 58
13. J.R. Brouwer, R. Willemsen, and B.A. Oostra Microsatellite repeat instability and neurological disease BioEssays 31 2009 71 83
14. S. Byrne Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study Lancet Neurol. 11 2012 232 240
15. D. Campos-Melo Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels Mol. Brain 6 2013 26
16. R. Cardani Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies Eur. J. Histochem. 53 2009 107 111
17. J.F. Chen The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat. Genet. 38 2006 228 233
18. A.S. Chen-Plotkin TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways J. Neurosci. 32 2012 11213 11227
19. B.A. Chestnut Epigenetic regulation of motor neuron cell death through DNA methylation J. Neurosci. 31 2011 16619 16636
20. A. Cistaro Role of PET and SPECT in the study of amyotrophic lateral sclerosis Biomed. Res. Int. 2014 2014 237437
21. A. Cistaro The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients Eur. J. Nucl. Med. Mol. Imaging. 41 2014 844 852
22. Ciura, S., et al., 2013. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol.
23. J.D. Cleary, and L.P. Ranum Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders Curr. Opin. Genet. Dev. 26C 2014 6 15
24. M. Cruts Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum Trends Neurosci. 36 2013 450 459
25. M.R. Davis Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT J. Nucl. Med. 44 2003 855 861
26. B. De Felice A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis Gene 508 2012 35 40
27. M. DeJesus-Hernandez Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS Neuron 72 2011 245 256
28. C.J. Donnelly RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention Neuron 80 2013 415 428
29. G.V. Echeverria, and T.A. Cooper RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity Brain Res. 1462 2012 100 111
30. M. Ehrich Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry Proc. Natl. Acad. Sci. U.S.A. 102 2005 15785 15790
31. M. Esteller Epigenetics in cancer N. Engl. J. Med. 358 2008 1148 1159
32. M.V. Evans-Galea FXN methylation predicts expression and clinical outcome in Friedreich ataxia Ann. Neurol. 71 2012 487 497
33. M. Fardaei Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells Hum. Mol. Genet. 11 2002 805 814
34. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
35. S.A. Fernandes Oligonucleotide-based therapy for FTD/ALS caused by the repeat expansion: a perspective J. Nucleic Acids 2013 2013 208245
36. J.M. Fernandez-Costa Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients Hum. Mol. Genet. 22 2013 704 716
37. B.R. Foerster, R.C. Welsh, and E.L. Feldman 25 years of neuroimaging in amyotrophic lateral sclerosis Nat. Rev. Neurol 9 2013 513 524
38. E. Gascon, and F.B. Gao Cause or effect: misregulation of microRNA pathways in neurodegeneration Front. Neurosci 6 2012 48
39. E. Gascon, and F.B. Gao The emerging roles of MicroRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders J. Neurogenet 2014
40. J.R. Gatchel, and H.Y. Zoghbi Diseases of unstable repeat expansion: mechanisms and common principles Nat. Rev. Genet. 6 2005 743 755
41. D.P. Gavin Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures J. Psychiatry Neurosci. 34 2009 232 237
42. T.F. Gendron Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS Acta Neuropathol 2013
43. T.F. Gendron, D.M. Cosio, and L. Petrucelli c9RAN translation: a potential therapeutic target for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia Expert Opin. Ther. Targets 17 2013 991 995
44. T.F. Gendron Mechanisms of toxicity in C9FTLD/ALS Acta Neuropathol. 127 2014 359 376
45. X. Gong MicroRNA-130b targets Fmr1 and regulates embryonic neural progenitor cell proliferation and differentiation Biochem. Biophys. Res. Commun. 439 2013 493 500
46. M.L. Gonzalgo, and G. Liang Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation Nat. Protoc. 2 2007 1931 1936
47. I. Grammatikakis Identification of MBNL1 and MBNL3 domains required for splicing activation and repression Nucleic Acids Res. 39 2010 2769 2780
48. S. Greco Deregulated microRNAs in myotonic dystrophy type 2 PLoS One 7 2012 e39732
49. A.R.D. Haeusler, C.J. Periz, G. Simko, E.A.J. Shaw, P.G. Kim, M.S. Maragakis, N.J. Troncoso, J.C. Pandey, A. Sattler, R. Rothstein, and J.D. Wang, J. C9orf72 nucleotide repeat structures initiate molecular cascades of disease Nature 2014
50. S. Haramati miRNA malfunction causes spinal motor neuron disease Proc. Natl. Acad. Sci. U.S.A. 107 2010 13111 13116
51. F. He, and P.K. Todd Epigenetics in nucleotide repeat expansion disorders Semin Neurol. 31 2011 470 483
52. S. Hu, J.A. Loo, and D.T. Wong Human body fluid proteome analysis Proteomics 6 2006 6326 6353
53. K. Jeyaseelan, K.Y. Lim, and A. Armugam MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion Stroke 39 2008 959 966
54. W.E. Klunk Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann. Neurol. 55 2004 306 319
55. E.D. Koval Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice Hum. Mol. Genet. 22 2013 4127 4135
56. T. Kruger Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery Proteomics Clin. Appl. 7 2013 123 135
57. I. Kwon Poly-dipeptides encoded by the C9ORF72 repeats bind nucleoli, impede RNA biogenesis, and kill cells Science 2014
58. C. Lagier-Tourenne Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration Proc. Natl. Acad. Sci. U.S.A 2013
59. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
60. Lee, Y.B., et al., 2013. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep.
61. J. Lemoine The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation Expert Rev. Mol. Diagn. 12 2012 333 342
62. Z. Li The FTD/ALS-associated RNA-binding protein TDP-43 regulates the robustness of neuronal specification through microRNA-9a in Drosophila Hum. Mol. Genet. 22 2013 218 225
63. S.C. Ling, M. Polymenidou, and D.W. Cleveland Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis Neuron 79 2013 416 438
64. D.Z. Liu Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures J. Cereb. Blood Flow Metab. 30 2010 92 101
65. Y. Liu C9ORF72 mutations in neurodegenerative diseases Mol. Neurobiol 2013
66. C.M. Lloyd Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil Brain 123 Pt 11 2000 2289 2296
67. C.M. Lloyd Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil Brain 123 Pt 11 2000 2289 2296
68. S. Maciotta, M. Meregalli, and Y. Torrente The involvement of microRNAs in neurodegenerative diseases Front. Cell Neurosci. 7 2013 265
69. C.J. Mahoney Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features Brain 135 2012 736 750
70. D.M. Mann Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72 Acta Neuropathol. Commun. 1 2013 68
71. L.J. Martin, and M. Wong Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms Neurotherapeutics 10 2013 722 733
72. M. Marullo Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease Brain Pathol. 20 2010 96 105
73. C.A. Mathis, Y. Wang, and W.E. Klunk Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain Curr. Pharm. Des. 10 2004 1469 1492
74. S. May C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration Acta Neuropathol 2014
75. M.F. Mehler Epigenetic principles and mechanisms underlying nervous system functions in health and disease Prog. Neurobiol. 86 2008 305 341
76. J.W. Miller Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy EMBO J. 19 2000 4439 4448
77. S. Mizielinska C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci Acta Neuropathol. 126 2013 845 857
78. S. Mizielinska C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins Science 2014
79. K. Mori Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins Acta Neuropathol. 126 2013 881 893
80. K. Mori The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS Science 339 2013 1335 1338
81. M. Neumann Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 2006 130 133
82. M. Polymenidou Misregulated RNA processing in amyotrophic lateral sclerosis Brain Res. 1462 2012 3 15
83. I.A. Qureshi, and M.F. Mehler Epigenetic mechanisms governing the process of neurodegeneration Mol. Aspects Med. 34 2013 875 882
84. I.A. Qureshi, and M.F. Mehler Developing epigenetic diagnostics and therapeutics for brain disorders Trends Mol. Med. 19 2013 732 741
85. P. Rao, E. Benito, and A. Fischer MicroRNAs as biomarkers for CNS disease Front. Mol. Neurosci 6 2013 39
86. A.E. Renton A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD Neuron 72 2011 257 268
87. G. Riboldi Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases Mol. Neurobiol 2014
88. G.M. Ringholz Prevalence and patterns of cognitive impairment in sporadic ALS Neurology 65 2005 586 590
89. J.D. Rothstein Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann. Neurol. 38 1995 73 84
90. H. Ryberg, and R. Bowser Protein biomarkers for amyotrophic lateral sclerosis Expert Rev. Proteomics. 5 2008 249 262
91. J. Sandoval Epigenetic biomarkers in laboratory diagnostics: emerging approaches and opportunities Expert Rev. Mol. Diagn. 13 2013 457 471
92. D. Sareen Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion Sci. Transl. Med. 5 2013 (208ra149)
93. C. Sellier Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor/ataxia syndrome Cell Rep. 3 2013 869 880
94. Z. Su Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS Neuron 2014
95. M. Therrien Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans PLoS One 8 2013 e83450
96. P.K. Todd, and H.L. Paulson RNA-mediated neurodegeneration in repeat expansion disorders Ann. Neurol. 67 2010 291 300
97. J.M. Toivonen MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis PLoS One 9 2014 e89065
98. J. Tost, and I.G. Gut DNA methylation analysis by pyrosequencing Nat. Protoc. 2 2007 2265 2275
99. M.R. Turner Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study Neurobiol. Dis. 15 2004 601 609
100. M.R. Turner Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET Brain 128 2005 1323 1329
101. K. Van Laere Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study JAMA Neurol 71 2014 553 561
102. B. Wightman, I. Ha, and G. Ruvkun Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans Cell 75 1993 855 862
103. A.H. Williams MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice Science 326 2009 1549 1554
104. Z. Xi Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion Am. J. Hum. Genet. 92 2013 981 989
105. Y. Yang Epigenetic regulation of neuron-dependent induction of astroglial synaptic protein GLT1 Glia 58 2010 277 286
106. Y.J. Zhang Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress Acta Neuropathol 2014
107. F. Zhou miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice Int. J. Clin. Exp. Pathol 6 2013 1826 1838
108. T. Zu Non-ATG-initiated translation directed by microsatellite expansions Proc. Natl. Acad. Sci. U.S.A. 108 2011 260 265
109. T. Zu RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia Proc. Natl. Acad. Sci. U.S.A. 110 2013 E4968 E4977
110. T. Zu RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia Proc. Natl. Acad. Sci. U.S.A 2013
111. C. Zuccato Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat. Genet. 35 2003 76 83